SSKN Stock Catalyst: STRATA Skin Sciences Demonstrates Superior Safety and Unprecedented Response Rates in Vitiligo Combination Therapy

STRATA Skin Sciences Inc. (OTC Link: SSKN) announced that its Excimer Laser combined with JAK Inhibitors has shown superior safety and unprecedented response rates in a new peer-reviewed publication on vitiligo combination therapy. The study underscores the potential of this treatment approach for patients suffering from vitiligo.

The publication details the significant improvements observed in both safety and efficacy when using the Excimer Laser in conjunction with JAK Inhibitors. These results were deemed superior to previous treatment methods, offering new hope for effective vitiligo management.

As of the latest data, STRATA Skin Sciences has a free float of 2,886,400 shares.

This summary was generated by AI from public sources and may contain errors. Not financial advice. Trade at your own risk.